Print

Orchid Chemicals & Pharmaceuticals Ltd.
Unaudited Financial Results for the Quater/Half year ended September 30, 2009
(Rs.Lakhs)
   
Unaudited
Unaudited
Audited
S.No
Particulars
Three months ended
30-Sep-09
Three months ended
30-Sep-08
Six months ended
30-Sep-09
Six months ended
30-Sep-08
Year ended
31-Mar-09
1
 Net Sales
30,484.59
33,914.02
61,066.48
62,169.14
115,676.96
2
 Other Operating Income
956.80
930.64
1,257.97
3,307.44
5,450.12
3
 Total Operating Income (1+2)
31,441.39
34,844.66
62,324.45
65,476.58
121,127.08
4
Total Expenditure
a) Decrease/(Increase) in Stock in trade
1,993.05
(3,503.58)
(684.94)
(9,159.74)
(6,478.32)
b) Material Cost
8,716.18
16,512.60
21,425.04
30,857.51
53,881.65
c) Purchase of Traded Goods
835.66
1,158.80
1,706.72
2,155.37
3,627.66
d) Employees Cost
2,999.79
2,955.46
5,896.01
5,830.27
12,288.43
e) Depreciation / Amortisation
3,887.15
3,310.75
7,619.71
6,428.39
12,997.21
f) Other Expenditure
8,046.44
7,688.57
18,639.62
16,927.77
29,235.42
g) Total
26,478.27
28,122.60
54,602.16
53,039.57
105,552.05
5
Profit from Operations before Other Income, Interest & Exceptional Item (3-4)
4,963.12
6,722.06
7,722.29
12,437.01
15,575.03
6
Other Income
0.93
0.88
1.39
1.62
301.85
7
Profit/(Loss) before Interest & Exceptional Item (5+6)
4,964.05
6,722.94
7,723.68
12,438.63
15,876.88
8
 Interest and Finance Charges
5,661.53
3,122.84
10,827.83
6,147.31
15,518.60
9
 Profit/(Loss) after interest but before Exceptional Item (7-8)
(697.48)
3,600.10
(3,104.15)
6,291.32
358.28
10
 Exceptional Item
(460.41)
(8,157.75)
(823.95)
(14,037.47)
(4,043.10)
11
 Profit/(Loss) before Tax (9+10)
(1,157.89)
(4,557.65)
(3,928.10)
(7,746.15)
(3,684.82)
12
 Tax expenses
 - Current Tax & Deferred Tax
162.28
(537.60)
368.12
(596.51)
1,371.65
 - Fringe Benefit Tax
-
46.00
-
81.00
161.00
13
 Net Profit/(Loss) After Tax (11-12)
(1,320.17)
(4,066.05)
(4,296.22)
(7,230.64)
(5,217.47)
14
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
7,044.21
7,044.21
7,044.21
7,044.21
7,044.21
15
 Reserves excluding Revaluation Reserves
-
-
59,977.31
16
 Basic Earnings per Share (EPS) Rs.
(1.87)*
(5.93)*
(6.10)*
(10.54)*
(7.61)
17
 Diluted Earnings per Share (EPS) Rs.
(1.87)*
(5.93)*
(6.10)*
(10.54)*
(7.61)
18
Aggregate of Public Shareholding
 

-Number of equity shares
55525904
55534904
55525904
55534904
55525904
  -Percentage of Shareholding
78.82
78.84
78.82
78.84
78.82
19
 Promoters and Promoter group shareholding
       
  a. Pledged / Encumbered          
  - Number of shares
4158000
  
4158000
  
6258000
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group)
27.88
27.88
41.95
  - Percentage of shares (as a % of the total share capital of company)
5.90
5.90
8.88
  b. Non - Encumbered          
  - Number of shares
10758172
  
10758172
  
8658172
  - Percentage of shares (as a % of the total shareholding of promoter and promoter group)
72.12
72.12
58.05
  - Percentage of shares (as a % of the total share capital of company)
15.28
15.28
12.30
             
* EPS is for the period (not annualised)
  • The above unaudited financial results were approved by the Board of Directors at its meeting held on Friday, 30th October, 2009 and have been subjected to limited review by the Statutory Auditors.
  • The Company is operating in single segment (i.e) "Pharmaceuticals".
  • The Company has exercised the option provided under the Companies (Accounting Standards) Amendment Rules, 2006 dated 31st March, 2009 in respect of AS 11. The amount remaining to be amortized in the financial statements as on 30th September, 2009 on account of exercising the above option is Rs. 2649.55 lakhs. If the same policy had been followed for the previous half year ended and quarter ended 30th September, 2008 then the profit before tax would have been Rs.6049.19 lakhs and Rs. 2688.93 lakhs and profit after tax would have been Rs.5282.81 lakhs and Rs.2338.27 lakhs respectively against the reported figures for the respective period.
  • Exceptional items represents exchange losses on FCCBs.
  • The Company received 1 complaint during the quarter ended 30th September, 2009 from the shareholder and no complaint was pending as on 30th September, 2009.
  • Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : October 30, 2009

For and on behalf of the Board

K.Raghavendra Rao
Managing Director